Link: https://lnkd.in/gbaXS6s2 Kirti Desai (Cpa), Tevogen Bio’s Chief Financial Officer, commented, “As we prepare to file our most recent quarterly financials, I want to highlight that Tevogen Bio has the funding it needs to sustain its operations and continue executing our strategy. We remain attentive to enhancing shareholder value, which is always top of mind for our team as we work to drive long-term success.” #TVGN #affordable #accessible #celltherapy #biotech
TEVOGEN BIO的动态
最相关的动态
-
???? We would totally get behind a campaign to make Snuggies acceptable science conference wear #cgt #cellandgenetherapy #genetherapy #celltherapy #cdmo #2024trends #globaldata #viralvector #biotech #equipment #development #manufacturing #boothpresent #poster #posterpresent
-
-
Come and have a look around! We'll show you how we overcome #solubility, #permeability or #PK profile problems with simple or sophisticated formulations. Drop me a message and we'll arrange a time. #FormulationDevelopment #ImmediateRelease #ControlledRelease #API #Peptide #Protein
If you would like a virtual tour please get in touch, we would love to show you around. #FormulationDevelopment #CDMO #biotech Claire Thompson Ali Parry Freya Liiv Graeme Parry Nicola Peters Mark Kuzniar Jack Beale Imogen Aikin
-
Partner at Simon-Kucher & Partners, Global Pricing & Market Access Expert for the Life Sciences Industry
Pricing and Market Access (P&MA) is no longer an afterthought but a critical determinant of a product's success. Learn how to develop a robust P&MA strategy that drives both commercial success and patient outcomes in this second webinar of our?Biotech growth series on "Navigating the path from innovation to market success"! This webinar is specifically geared towards smaller / mid-sized biotechs and will cover: 1) Insights into state-of-the-art P&MA decision making from start to finish and the key steps to ensure global P&MA success 2) Techniques for navigating the tradeoff between price, reimbursement, and physician uptake to optimize your revenue potential 3) Current and crucial global P&MA trends (e.g., IRA/PDAP in the US, EU JCA) and their implications for your strategy development and required skillset I look forward to seeing you on Oct 16!
Pricing and Market Access (P&MA) is no longer just a box to check—it's a critical determinant of your product’s success. Join our next webinar in the Better Biotech Growth series, where our expert, Mark Kastner, will share strategies for navigating the complex world of P&MA and ensuring your breakthrough reaches the patients who need it most! Secure your seat here: skp.link/p0fr #Biotech #CommercialExcellence #SimonKucher #BiotechGrowth #BetterBiotechGrowth
-
-
What's your potential ROI? Calculate the cost and efficiency benefits that leveraging #GenAI and #LLMs through LifeSphere Safety can bring to your #PV operations in minutes with our ROI calculator: https://lnkd.in/grfmh5gq #lifesciences #pvoperations #roisavings #biotech #pharmatech #drugsafety
-
-
Helping Biotech & Pharmaceutical leadership accelerate their drug discovery efforts and optimize their lab operations. | Senior Account Executive
Scigilian is live at BioIT World 2024. Stop by booth 512 to learn how we can help optimize your lab operations. ????#biotech #drugdiscovery #Scigilian
-
-
Horticultural advisor,leader,and plant health specialist. Stray bioscience partners with your business to create and maintain an unmatched footprint in your jurisdiction. ??????strive to thrive?????? Stray bioscience FTW
Numbers are better, operating costs lower, and increase in quality We can support your team or take over entirely as a managing partner this is what we do at stray bioscience #cannabisindistry #expert ??????strive to thrive?????? Stray bioscience
-
Kane Biotech will announce its fourth quarter and full year 2023 financial results after market close today, Tuesday, March 26, 2024. Kane Biotech management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Participants must register for the call using this link: https://bit.ly/3VqDCmO Pre-register to Q4 to receive the dial-in numbers and unique PIN to access the call seamlessly. It is recommended that you join 10 minutes before the event, though you may pre-register at any time. A webcast of the call will be available on the company's website at www.kanebiotech.com in the Investor section of the Kane Biotech website at ir.kanebiotech.com. #Petcare #Biotech #BioTechnology #Biofilm #biofilms #PressRelease #BusinessGrowth #WoundCare #PetHealth #HumanHealth #Innovation #SmallCap #Research #Development #KaneBio
-
-
#VeevaSummit is quickly approaching! Sarah Caldwell, general manager, Veeva Crossix, shares her thoughts on what she’s looking forward to the most. Let us know what you’re most excited about and register in the comments below. ?? #biotechnology
The countdown to #VeevaSummit is on. We’re heading back to Boston May 7 - 8, and I’m thrilled to share some of the things I’m most looking forward to this time around: 1. Reconnecting with friends and colleagues 2. Sharing insights to navigate today’s media landscape 3. Taking a walk around Boston Common and the Public Garden What are you looking forward to at Summit? Let me know in the comments. Take a look at the Veeva Crossix Zone agenda to see what we have planned:?https://bit.ly/3Vi3KQN #VeevaSummit #biotechnology #pharmamarketing
-
-
#Biotechs, the road to getting a drug to the clinic can be filled with speed bumps.. This webinar provides guidance to navigate these roadblocks. https://okt.to/VmB1Fc #drugdevelopment
-
Check out Do Kim's latest report on Vivos 2Q24 earnings results. Read about how their new distribution model and strong patient demand for its OSA treatments is setting the stage for a significant revenue surge in 2H24. #VVOS #Biotech #SleepApnea #SmallCapStocks #InvestorRelations #EquityResearch #WTR #WaterTowerResearch https://lnkd.in/ez635UUE
-
